Exel’s Q2 was encouraging as EBIT recovered significantly after a challenging period of missing dema...
We expect flat sales for H2 with a decrease in domestic net sales due to non-recurring wholesale del...
Exel’s Q2 results landed clearly above our estimates as the EUR 26.
Dovre’s Q2 results were a bit higher than we estimated as Project Personnel and Consulting came in s...
Aspo’s Q2 earnings were basically in line with estimates.
Ascelia’s Q2 confirmed a contained OPEX base. With support from the recent SPARKLE success and the o...
CirChem (”CirChem” eller ”Bolaget”) har publicerat Bolagets delårsrapport för det andra kvartalet 20...
Redeye is positive to Bredband2’s acquisition of Bredbandsson, adding about 0.
Redeye updates on Embracer after Q1-results which were overall close to our forecast, albeit with so...
Redeye states that BeammWave’s Q2 report aligned with expectations.
Björn Borg (”Björn Borg” or ”the Company”) published its Q2 report for 2024 on the 16th of August, 2...
Pharma Equity Group (“PEG” or “the Company”) published its Q2 report for 2024 on the 16th of August ...
Redeye states BeammWave's Q2 report aligned with expectations.
Redeye gives its initial comments on the Q2 2024 report from Precise Biometrics.
Lumi Gruppen continues to see high demand for its ONH courses, reporting a 20% y/y increase in autum...
